Rare And Cutaneous Non-Hodgkin Lymphoma Registry
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 174
- 试验地点
- 130
- 主要终点
- Sub-groups of these diseases that could be targeted for future biologic, pathologic, or therapeutic studies
研究概览
简要总结
This research study is collecting and storing tissue samples from patients with rare or cutaneous non-Hodgkin lymphoma. Collecting and storing samples of tissue from patients with cancer to test in the laboratory may help the study of cancer in the future.
详细描述
OBJECTIVES:
I. To determine the clinical features, treatment, and outcome of patients with rare or cutaneous pediatric non-Hodgkin lymphoma (NHL).
II. To determine the pathologic and biologic features of these diseases, including molecular diagnostics and flow cytometry.
III. To establish a bank of these pathologically reviewed diseases and make specimens of blood and tissue available to qualified researchers.
IV. To determine sub-groups of these diseases that could be targeted for future biologic, pathologic, or therapeutic studies.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- — 至 21 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of NHL
- •Any histology, except for Burkitt or Burkitt-like, diffuse large B-cell, anaplastic large cell, or lymphoblastic lymphoma
- •Primary CNS, primary cutaneous NHL, or lymphoproliferative diseases of any histology allowed
- •Pathological specimen from site not treated within the past 6 months
- •Must have specimens available
- •At least 6 months since prior chemotherapy irradiation to study lesion
- •At least 2 weeks since prior steroids
排除标准
- 未提供
结局指标
主要结局
Sub-groups of these diseases that could be targeted for future biologic, pathologic, or therapeutic studies
时间窗: Up to 5 years
Pathologic and biologic features of these diseases, including molecular diagnostics and flow cytometry
时间窗: Up to 5 years
Establishment of a bank of these pathologically reviewed diseases and make specimens of blood and tissue available to qualified researchers
时间窗: Up to 5 years
Clinical features, treatment, and outcomes
时间窗: Up to 5 years
次要结局
未报告次要终点